Next, to exclude possible experimental artifacts due to the use of engineered HaCaT cells overexpressing E6, we also investigated the fate of hScrib after proteasome inhibition in cellular models of HPV16-driven cervical cancer endogenously expressing E6. This evidence concerns the gene SCRIB and cervical cancer.